Unigestion Holding’s CVS Health CVS Stock Holding History

Unigestion Holding’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-28,667	Closed	-$2.26M	–	165
2024 Q2	$2.26M	Hold	28,667	–	–	0.12%	83
2024 Q1	$2.29M	Hold	28,667	–	–	0.11%	84
2023 Q4	$2.26M	Sell	28,667 -8,151	-22%	-$580K	0.12%	83
2023 Q3	$2.58M	Sell	36,818 -10,563	-22%	-$748K	0.16%	86
2023 Q2	$3.26M	Sell	47,381 -1,043	-2%	-$74.2K	0.19%	81
2023 Q1	$3.62M	Sell	48,424 -1,476	-3%	-$124K	0.2%	82
2022 Q4	$4.66M	Buy	49,900 +27,013	+118%	+$2.61M	0.25%	73
2022 Q3	$2.22M	Buy	22,887 +8,259	+56%	+$818K	0.13%	99
2022 Q2	$1.35M	Buy	+14,628	New	+$1.43M	0.08%	118
2021 Q2	–	Sell	-12,679	Closed	-$954K	–	238
2021 Q1	$954K	Buy	12,679 +3,329	+36%	+$242K	0.03%	158
2020 Q4	$639K	Sell	9,350 -421	-4%	-$27.4K	0.02%	183
2020 Q3	$571K	Sell	9,771 -498	-5%	-$31K	0.02%	151
2020 Q2	$667K	Buy	+10,269	New	+$647K	0.02%	144

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Unigestion Holding's CVS Position: Q3 2024 in Review

Unigestion Holding sold out of CVS Health (CVS) in Q3 2024, closing a stake of 28,667 shares — an estimated $2.26M sold.

Unigestion Holding first reported a position in CVS in Q2 2020 and held it in 13 quarters. The position peaked at $4.66M in Q4 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Unigestion Holding reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Unigestion Holding sold 28,667 CVS Health shares in Q3 2024, an estimated $2.26M.
Unigestion Holding first reported a position in CVS Health in Q2 2020 and held it in 13 quarters.
Unigestion Holding's CVS Health position peaked at $4.66M in Q4 2022.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Unigestion Holding's 13F filing for Q3 2024, filed 19 Nov 2024.